Cart
sales@molnova.com
Imidapril HCl
CAS No. 89396-94-1
Imidapril HCl( TA-6366 )
Catalog No. M19235 CAS No. 89396-94-1
Imidapril HCl is an angiotensin-converting enzyme (ACE) inhibitor with IC50 of 2.6 nM, used for the treatment of hypertension.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 29 | In Stock |
|
| 5MG | 28 | In Stock |
|
| 10MG | 42 | In Stock |
|
| 25MG | 88 | In Stock |
|
| 50MG | 132 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameImidapril HCl
-
NoteResearch use only, not for human use.
-
Brief DescriptionImidapril HCl is an angiotensin-converting enzyme (ACE) inhibitor with IC50 of 2.6 nM, used for the treatment of hypertension.
-
DescriptionImidapril HCl is an angiotensin-converting enzyme (ACE) inhibitor with IC50 of 2.6 nM, used for the treatment of hypertension.
-
In Vitro——
-
In Vivo——
-
SynonymsTA-6366
-
PathwayGPCR/G Protein
-
TargetProstaglandin Receptor
-
RecptorACE
-
Research AreaCardiovascular Disease
-
Indication——
Chemical Information
-
CAS Number89396-94-1
-
Formula Weight441.91
-
Molecular FormulaC20H27N3O6·HCl
-
Purity>98% (HPLC)
-
SolubilityDMSO : 50 mg/mL 113.15 mM; H2O : 50 mg/mL 113.15 mM
-
SMILESCCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2[C@@H](CN(C2=O)C)C(=O)O.Cl
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Thoulon F, Woehrlé F, Boisramé B.J Vet Cardiol. 2003 May;5(1):29-34.
molnova catalog
related products
-
Gestonorone Capronat...
Gestonorone Capronate? is a progesterone used in benign prostatic hyperplasia and endometrial cancer studies.
-
Terbogrel
Terbogrel is an oral thromboxane A2 receptor antagonist (IC50 is about 10 nM) and thromboxane A2 synthase inhibitor (IC50 is about 10 nM).
-
TP-16
TP-16 is a novel potent and selective EP4 antagonist that blocks the function of IMCs and enhances cytotoxic T cell-mediated tumor elimination in vivo.
